<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-058326</identifier>
<setSpec>0001-6640</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Probiotics for the mother-infant dyad (I)</dc:title>
<dc:description xml:lang="en">The design of probiotics specifically targeted to the infant population    is attractive to both the medical community and the industrial    sector since they could facilitate the creation of a safe and    efficient barrier against pathogenic microorganisms and, in addition,    they can contribute to the maturation of the gut-associated    lymphoid tissue. At present, there is scientific evidence supporting    the beneficial effect of certain probiotic strains on infant health,    particularly in relation to the reduction in the duration and/or severity    of diarrheal episodes associated with acute infectious gastroenteritis,    including those secondary to antibiotic therapy. On the    other hand, some strains may exert preventive and therapeutic    effects on atopic eczema and other allergic diseases, although    additional clinical studies will be required before probiotics can be    used for the treatment of such conditions on a widespread basis</dc:description>
<dc:creator>Rodríguez, J. M</dc:creator>
<dc:creator>Dalmau, J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El diseño de probióticos dirigidos a la población infantil ha despertado    interés en los sectores médico e industrial, ya que    podrían facilitar la creación de una barrera segura y eficaz frente    a microrganismos patógenos y, además, contribuir a la maduración    del tejido linfoide asociado a la mucosa intestinal.    Actualmente, existen evidencias sobre el efecto beneficioso    que algunos probióticos ejercen sobre la salud infantil, particularmente    en lo concerniente a la reducción de la duración y    severidad de los procesos diarreicos asociados a gastroenteritis    infecciosas agudas, incluyendo aquellas asociadas a la antibioterapia.    Por otra parte, ciertas cepas podrían ejercer efectos    preventivos y terapéuticos sobre el eccema atópico y otras    enfermedades de base alérgica, aunque serán necesarios más    estudios clínicos antes de que se generalice el empleo de probióticos    para el tratamiento de estas enfermedades</dc:description>
<dc:source>Acta Pediatr Esp;65(9): 452-457, oct. 2007. ilus, tab</dc:source>
<dc:identifier>ibc-058326</dc:identifier>
<dc:title xml:lang="es">Probióticos para el binomio madre-hijo (I)</dc:title>
<dc:subject>^d7399</dc:subject>
<dc:subject>^d9226</dc:subject>
<dc:subject>^d3893^s22038</dc:subject>
<dc:subject>^d5651^s22016</dc:subject>
<dc:subject>^d9082^s22031</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d7145^s22016</dc:subject>
<dc:subject>^d3893^s22054</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d9082^s22038</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d7145^s22012</dc:subject>
<dc:subject>^d7406^s22031</dc:subject>
<dc:subject>^d5900^s22012</dc:subject>
<dc:subject>^d22226</dc:subject>
<dc:subject>^d3994^s22067</dc:subject>
<dc:subject>^d5900^s22038</dc:subject>
<dc:subject>^d5900^s22016</dc:subject>
<dc:subject>^d5900^s22017</dc:subject>
<dc:subject>^d33510^s22000</dc:subject>
<dc:subject>^d3994^s22038</dc:subject>
<dc:subject>^d33510^s22065</dc:subject>
<dc:subject>^d33510^s22073</dc:subject>
<dc:subject>^d8396^s22031</dc:subject>
<dc:type>article</dc:type>
<dc:date>200710</dc:date>
</metadata>
</record>
</ibecs-document>
